Page 2 - Test Assessment Program News Today

/PRNewswire/ -- Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: Today, the FDA issued an...

Despite a few less successful elements, the overall portfolio increased test availability and RADx is now becoming a model for federal investing.

Meet the 19 recipients of this year’s Award of Distinction, the highest honor given to university staff, and learn about their outstanding contributions to the Emory community.

As COVID-19 rapidly expanded throughout the world in April 2020, many in the biomedical technology community voiced significant concerns about the lack of available diagnostic tests. At that time, testing for SARS-CoV-2, the coronavirus that causes COVID-19, was conducted exclusively in clinical laboratories by order of a health-care provider. “Over the counter” (OTC) tests did…

Pfizer and BioNTech report a clinical trial has shown their vaccine booster shot provides effective protection from COVID-19 in children.

The moves come amid nationwide reports of shortages and rising case rates fueled by the omicron variant.

The agency also shortened the minimum timeframe for people who received the primary Pfizer vaccine series to seek a booster to five months from six.

Democrats have ramped up pressure on the Biden administration to invest more in at-home COVID-19 testing to address supply shortages, arguing that people are missing a key public health tool as a threatening variant emerges.

The COVID-19 Report is a compilation of coronavirus news, analysis, and insights from around the world to help life sciences and health care companies stay current in this challenging...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in healthcare regulations, notices, and guidance; federal legislation and congressional...